Safety and Effectiveness of a New Anti-HIV Drug (AG1549) in Combination With Other Anti-HIV Drugs in HIV-Infected Patients

NCT00004998 · clinicaltrials.gov ↗

PHASE2

Phase

SUSPENDED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Lamivudine/Zidovudine
DRUG: Capravirine
DRUG: Nelfinavir mesylate

Sponsor

Agouron Pharmaceuticals